CleanSpace Holdings Limited (ASX:CSX)
0.5000
+0.0100 (2.04%)
Oct 7, 2026, 3:24 PM AEST
CleanSpace Holdings Revenue
In the fiscal year ending June 30, 2026, CleanSpace Holdings had annual revenue of 19.82M AUD with 0.29% growth. CleanSpace Holdings had revenue of 9.75M in the half year ending June 30, 2026, with 15.69% growth. That makes CleanSpace Holdings the world's 35,794th largest company by revenue and 626th in Australia.
Revenue
19.82M
Revenue Growth
+0.29%
P/S Ratio
2.00
Revenue / Employee
374.00K
Employees
53
Market Cap
39.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 19.82M | 57.29K | 0.29% |
| Jun 30, 2025 | 19.76M | 4.04M | 25.72% |
| Jun 30, 2024 | 15.72M | 3.63M | 30.01% |
| Jun 30, 2023 | 12.09M | -1.27M | -9.47% |
| Jun 30, 2022 | 13.36M | -36.57M | -73.24% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 114.53M |
| Compumedics | 61.88M |
| Nova Eye Medical | 34.87M |
| Cyclopharm | 34.42M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |